Cargando…
Renal Sympathetic Denervation for Hypertension
Arterial hypertension is the most prevalent global modifiable risk factor for cardiovascular morbidity and mortality. Despite the availability of numerous pharmacologic treatments, many patients do not achieve guideline-recommended blood pressure targets. Therefore, renal sympathetic denervation (RD...
Autores principales: | Guber, Kenneth, Kirtane, Ajay J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546727/ https://www.ncbi.nlm.nih.gov/pubmed/36217529 http://dx.doi.org/10.1016/j.ekir.2022.06.019 |
Ejemplares similares
-
Renal Sympathetic Denervation in the Treatment of Resistant Hypertension
por: Sánchez-Álvarez, Catalina, et al.
Publicado: (2014) -
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
por: Papademetriou, Vasilios, et al.
Publicado: (2011) -
Renal Sympathetic Denervation for Resistant Hypertension Treatment -
Current Perspectives
por: Brandão, Andréa Araujo, et al.
Publicado: (2013) -
Drug-resistant Hypertension: Is Renal Sympathetic Denervation the Answer?
por: Thompson, Keith A., et al.
Publicado: (2011) -
Catheter-based renal sympathetic nerve denervation on hypertension management outcomes
por: Singh, Som P, et al.
Publicado: (2022)